Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Immunomedics (IMMU) - moderated -- Ignore unavailable to you. Want to Upgrade?

To: tbone0096 who wrote (8407)	12/2/2009 7:55:56 PM
From: li3511	Respond to of 63330

> will look forward to hearing what responses you got to those questions Me too.

To: tbone0096 who wrote (8407)	12/3/2009 9:27:19 AM
From: goldsachstrader	Read Replies (3) \| Respond to of 63330

only 3 people asked questions and we were only allowed to ask 3 questions. incredible. A.R.S. they said the bond market is easing up and hopefully they get cash within year. No comment on milestone payments. they said have lots of analysts(people) asking for info, but most analysts want the Full data on emab trial before they say anything. gave gorman alittle hell about why we dont have a conf call, had to ask him that in lounge because Dr closed meeting, in regard to secondary they said they filed a S3 because they had a S3 expiring and wanted to have one on file for the future. i think it was bs. i think they were playing the market with there stock because they thought the stock would get another pop up if it got accepted for last breaking abstract.